Program in Physiology and Experimental Medicine (A.M.L.W., P.D., X.L., M.Y., S.I.), Program in Developmental and Stem Cell Biology (P.A.H.), Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada; Departments of Pediatrics (S.I.), and Pharmacology & Toxicology (A.M.L.W., D.S.R., J.M., P.A.H., S.I.), University of Toronto, Toronto, Ontario, Canada; Department of Pathology (C.V.C.), Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Program in Experimental Therapeutics, University of Maryland Greenebaum Cancer Center, and the Baltimore Veterans Affairs Medical Center, Baltimore, Maryland (D.D.R.).

Program in Physiology and Experimental Medicine (A.M.L.W., P.D., X.L., M.Y., S.I.), Program in Developmental and Stem Cell Biology (P.A.H.), Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada; Departments of Pediatrics (S.I.), and Pharmacology & Toxicology (A.M.L.W., D.S.R., J.M., P.A.H., S.I.), University of Toronto, Toronto, Ontario, Canada; Department of Pathology (C.V.C.), Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Program in Experimental Therapeutics, University of Maryland Greenebaum Cancer Center, and the Baltimore Veterans Affairs Medical Center, Baltimore, Maryland (D.D.R.).

Program in Physiology and Experimental Medicine (A.M.L.W., P.D., X.L., M.Y., S.I.), Program in Developmental and Stem Cell Biology (P.A.H.), Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada; Departments of Pediatrics (S.I.), and Pharmacology & Toxicology (A.M.L.W., D.S.R., J.M., P.A.H., S.I.), University of Toronto, Toronto, Ontario, Canada; Department of Pathology (C.V.C.), Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Program in Experimental Therapeutics, University of Maryland Greenebaum Cancer Center, and the Baltimore Veterans Affairs Medical Center, Baltimore, Maryland (D.D.R.).

Program in Physiology and Experimental Medicine (A.M.L.W., P.D., X.L., M.Y., S.I.), Program in Developmental and Stem Cell Biology (P.A.H.), Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada; Departments of Pediatrics (S.I.), and Pharmacology & Toxicology (A.M.L.W., D.S.R., J.M., P.A.H., S.I.), University of Toronto, Toronto, Ontario, Canada; Department of Pathology (C.V.C.), Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Program in Experimental Therapeutics, University of Maryland Greenebaum Cancer Center, and the Baltimore Veterans Affairs Medical Center, Baltimore, Maryland (D.D.R.).

Program in Physiology and Experimental Medicine (A.M.L.W., P.D., X.L., M.Y., S.I.), Program in Developmental and Stem Cell Biology (P.A.H.), Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada; Departments of Pediatrics (S.I.), and Pharmacology & Toxicology (A.M.L.W., D.S.R., J.M., P.A.H., S.I.), University of Toronto, Toronto, Ontario, Canada; Department of Pathology (C.V.C.), Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Program in Experimental Therapeutics, University of Maryland Greenebaum Cancer Center, and the Baltimore Veterans Affairs Medical Center, Baltimore, Maryland (D.D.R.).

Program in Physiology and Experimental Medicine (A.M.L.W., P.D., X.L., M.Y., S.I.), Program in Developmental and Stem Cell Biology (P.A.H.), Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada; Departments of Pediatrics (S.I.), and Pharmacology & Toxicology (A.M.L.W., D.S.R., J.M., P.A.H., S.I.), University of Toronto, Toronto, Ontario, Canada; Department of Pathology (C.V.C.), Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Program in Experimental Therapeutics, University of Maryland Greenebaum Cancer Center, and the Baltimore Veterans Affairs Medical Center, Baltimore, Maryland (D.D.R.).

Program in Physiology and Experimental Medicine (A.M.L.W., P.D., X.L., M.Y., S.I.), Program in Developmental and Stem Cell Biology (P.A.H.), Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada; Departments of Pediatrics (S.I.), and Pharmacology & Toxicology (A.M.L.W., D.S.R., J.M., P.A.H., S.I.), University of Toronto, Toronto, Ontario, Canada; Department of Pathology (C.V.C.), Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Program in Experimental Therapeutics, University of Maryland Greenebaum Cancer Center, and the Baltimore Veterans Affairs Medical Center, Baltimore, Maryland (D.D.R.).

Program in Physiology and Experimental Medicine (A.M.L.W., P.D., X.L., M.Y., S.I.), Program in Developmental and Stem Cell Biology (P.A.H.), Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada; Departments of Pediatrics (S.I.), and Pharmacology & Toxicology (A.M.L.W., D.S.R., J.M., P.A.H., S.I.), University of Toronto, Toronto, Ontario, Canada; Department of Pathology (C.V.C.), Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Program in Experimental Therapeutics, University of Maryland Greenebaum Cancer Center, and the Baltimore Veterans Affairs Medical Center, Baltimore, Maryland (D.D.R.).

Program in Physiology and Experimental Medicine (A.M.L.W., P.D., X.L., M.Y., S.I.), Program in Developmental and Stem Cell Biology (P.A.H.), Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada; Departments of Pediatrics (S.I.), and Pharmacology & Toxicology (A.M.L.W., D.S.R., J.M., P.A.H., S.I.), University of Toronto, Toronto, Ontario, Canada; Department of Pathology (C.V.C.), Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Program in Experimental Therapeutics, University of Maryland Greenebaum Cancer Center, and the Baltimore Veterans Affairs Medical Center, Baltimore, Maryland (D.D.R.).

Program in Physiology and Experimental Medicine (A.M.L.W., P.D., X.L., M.Y., S.I.), Program in Developmental and Stem Cell Biology (P.A.H.), Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada; Departments of Pediatrics (S.I.), and Pharmacology & Toxicology (A.M.L.W., D.S.R., J.M., P.A.H., S.I.), University of Toronto, Toronto, Ontario, Canada; Department of Pathology (C.V.C.), Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Program in Experimental Therapeutics, University of Maryland Greenebaum Cancer Center, and the Baltimore Veterans Affairs Medical Center, Baltimore, Maryland (D.D.R.).